KEAP1 and hepatocellular carcinoma: Our study aimed to systematically investigate the role of PP1A in HCC, particularly in Lenvatinib resistance, and to explore the relationship between PP1A and the Keap1‐Nrf2 signaling pathway, and explore its impact on antitumor immune response.